Oral Administration and Absorption

Oral administration delivers a drug by mouth so that it is swallowed and absorbed, mainly across the lining of the small intestine, before entering the systemic circulation. It is the most widely used route because it is convenient and non-invasive, but absorption depends on the drug dissolving in gastrointestinal fluids and crossing the intestinal epithelium, and a fraction may be lost to metabolism before reaching the bloodstream.

Definition

Oral administration is delivery of a drug by the gastrointestinal route after swallowing, with systemic absorption determined chiefly by the drug's dissolution in gastrointestinal fluid and its permeability across the intestinal epithelium.

Scope

This topic covers the dissolution and permeation steps that govern oral absorption, the Biopharmaceutics Classification System that organizes drugs by solubility and permeability, first-pass metabolism, and formulation strategies used to improve oral bioavailability. It is a pharmaceutical and biopharmaceutical reference and does not provide dosing or prescribing guidance.

Core questions

• What limits a drug's oral absorption: how readily it dissolves, or how readily it permeates the gut wall?
• How does first-pass metabolism reduce the amount of drug reaching the systemic circulation?
• How is oral bioavailability predicted from in vitro and preclinical data?
• Which formulation strategies raise the bioavailability of poorly soluble drugs?

Key concepts

• Dissolution
• Intestinal permeability
• Oral bioavailability
• First-pass metabolism
• Solubility-limited absorption
• Enabling formulations

Key theories

Biopharmaceutics Classification System (BCS)

The BCS classifies orally administered drugs into four classes by aqueous solubility and intestinal permeability, predicting which absorption step (dissolution or permeation) is rate-limiting and supporting regulatory decisions such as biowaivers.

Mechanisms

After a solid dosage form is swallowed it must disintegrate and the drug must dissolve in gastrointestinal fluid before it can permeate the intestinal epithelium and reach the portal circulation. The Biopharmaceutics Classification System frames these two steps by sorting drugs according to solubility and permeability, identifying which is rate-limiting (Amidon et al., 1995). Drug that does reach the portal blood may be partly metabolized in the gut wall and liver before reaching the systemic circulation, the first-pass effect, which lowers bioavailability. For poorly water-soluble compounds, dissolution is often limiting, motivating enabling formulations such as solubilized, amorphous, or lipid-based systems (Williams et al., 2013). Predicting the resulting human exposure integrates these solubility, permeability, and clearance inputs (Heimbach et al., 2009).

Clinical relevance

Oral bioavailability and first-pass metabolism explain why some drugs are effective by mouth while others must be given by another route, and they inform appraisal of why products are formulated and labelled as they are. This entry describes absorption principles for reference and is not a basis for choosing or adjusting an individual's therapy.

Evidence & guidelines

The Biopharmaceutics Classification System underpins regulatory frameworks for oral bioavailability and biowaivers (Amidon et al., 1995). Reviews of solubility-enabling formulation summarize approaches for poorly soluble drugs (Williams et al., 2013), and standard pharmaceutics texts codify oral dosage-form design (Aulton & Taylor, 2018).

History

Oral dosage forms are among the oldest medicines, but a quantitative understanding of oral absorption matured in the late twentieth century. The 1995 Biopharmaceutics Classification System gave the field a unifying way to relate a drug's solubility and permeability to its absorption and to regulatory expectations, after which solubility-enabling formulation became a major focus of development for poorly soluble compounds (Amidon et al., 1995; Williams et al., 2013).

Key figures

• Gordon Amidon
• Hans Lennernas
• Christopher Porter
• William Charman

Seminal works

• amidon-1995
• williams-2013

Frequently asked questions

Why is a drug sometimes less potent when taken by mouth than when injected?

Orally administered drug must dissolve and cross the intestinal wall, and a portion can be metabolized in the gut and liver before reaching the systemic circulation, so less active drug may become available than after injection.

What is the Biopharmaceutics Classification System?

It is a framework that sorts oral drugs into four classes based on their water solubility and intestinal permeability, which helps predict whether dissolution or permeation limits absorption and informs regulatory decisions.